Experience with Alpha-Lipoic Acid plus Low-Dose Naltrexone (ALA/N) for various cancers and autoimmune disease.

Condition: Autoimmune disease

Category: Cancer,_rheumatology

Date: 2013

Author: Burton M. Berkson

Type: PPT

Dr. Burton M. Berkson’s presentation from the 2013 LDN Conference discussing the role of LDN in the treatment of various cancers and autoimmune disorders.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Not Finding What You're Looking For?

Fill out the form below to let us know.

>